ReviewSurgical endoscopy2026
Advanced robotic liver surgery.
Review in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic surgery represents the most advanced evolution of minimally invasive liver surgery, progressively extending its application from minor resections to highly complex hepatobiliary procedures. Beyond the traditional definition of major hepatectomy, surgical complexity is increasingly determined by anatomical location, proximity to major vascular and biliary structures, patient-related factors, and integration within multimodal treatment strategies.
methodsA narrative and critical review of the literature was conducted using PubMed/MEDLINE, focusing on robotic liver resections performed in technically complex settings. Case series, original studies, meta-analyses, consensus statements, and guidelines from high-volume centers with expertise in minimally invasive liver surgery were preferentially included.
resultsCurrent evidence supports the technical feasibility and safety of robotic liver surgery across multiple domains of complexity, including resections of posterosuperior segments, parenchyma-sparing procedures for centrally located tumors, vascular and biliary resections with reconstruction, and resections following liver volume augmentation strategies. Selected experiences also demonstrate feasibility in extreme scenarios such as robotic living donor hepatectomy and liver transplantation. Compared with open surgery, robotic approaches are associated with reduced surgical trauma and shorter hospital stay. Potential advantages over laparoscopy are mainly technical and procedure specific. Long-term oncological superiority has not been conclusively demonstrated in the current literature.
conclusionsRobotic liver surgery has matured into a versatile platform capable of supporting highly complex hepatobiliary procedures in carefully selected patients. Its value lies in enhancing technical precision and facilitating minimally invasive procedures within established oncological and transplant indications. Widespread adoption should remain limited to specialized, high-volume centers with structured training and multidisciplinary expertise.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.